Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia

被引:130
作者
Charles, Edgar D. [1 ]
Green, Rashidah M. [1 ]
Marukian, Svetlana [1 ]
Talal, Andrew H. [2 ]
Lake-Bakaar, Gerond V. [2 ]
Jacobson, Ira M. [2 ]
Rice, Charles M. [1 ]
Dustin, Lynn B. [1 ]
机构
[1] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Med, Div Gastroenterol & Hepatol, New York, NY USA
关键词
D O I
10.1182/blood-2007-07-101717
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis C virus (HCV) is associated with B-cell lymphoproliferative disorders such as mixed cryoglobulinemia (MC) and B-cell non-Hodgkin lymphoma (B-NHL). The pathogenesis of these disorders remains unclear, and it has been proposed that HCV drives the proliferation of B cells. Here we demonstrate that certain HCV+MC+ subjects have clonal expansions of immunoglobulin M (IgM)(+)kappa(+)IgD(low/-)CD21(low) CD27(+) B cells. Using RT-PCR to amplify Ig from these singly sorted cells, we show that these predominantly rheumatoid factor-encoding V(H)1-69/J(H)4 and V(kappa)3-20 gene segment-restricted cells have low to moderate levels of somatic hypermutations. Ig sequence analysis suggests that antigen selection drives the generation of mutated clones. These findings lend further support to the notion that specific antigenic stimulation leads to B-cell proliferation in HCV MC and that chronic B-cell stimulation may set the stage for malignant transformation and the development of B-NHL. The finding that these hypermutated, marginal zone-like IgM(+)CD27(+) B cells are clonally expanded in certain subjects with MC offers insight into mechanisms of HCV-associated MC and B-cell malignancy. This study was registered at www.clinicaltrials.gov as NCT00219999.
引用
收藏
页码:1344 / 1356
页数:13
相关论文
共 76 条
[21]   New therapeutic strategies for hepatitis C [J].
Di Bisceglie, AM ;
McHutchinson, J ;
Rice, CM .
HEPATOLOGY, 2002, 35 (01) :224-231
[22]  
Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602
[23]   HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA [J].
FERRI, C ;
CARACCIOLO, F ;
ZIGNEGO, AL ;
LACIVITA, L ;
MONTI, M ;
LONGOMBARDO, G ;
LOMBARDINI, F ;
GRECO, F ;
CAPOCHIANI, E ;
MAZZONI, A ;
MAZZARO, C ;
PASERO, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) :392-394
[24]   CLONAL B-CELL EXPANSIONS IN PERIPHERAL-BLOOD OF HCV-INFECTED PATIENTS [J].
FRANZIN, F ;
EFREMOV, DG ;
POZZATO, G ;
TULISSI, P ;
BATISTA, F ;
BURRONE, OR .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (03) :548-552
[25]   Hepatitis C virus, B-cell proliferation and lymphomas [J].
Gasparotto, D ;
De Re, V ;
Boiocchi, M .
LEUKEMIA & LYMPHOMA, 2002, 43 (04) :747-751
[26]  
GIORDANO TP, 2007, JAMA-J AM MED ASSOC, V25, P71
[27]  
Gorevic PD, 2002, MANUAL CLIN LAB IMMU, P97
[28]   Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection [J].
Hermine, O ;
Lefrère, F ;
Bronowicki, JP ;
Mariette, X ;
Jondeau, K ;
Eclache-Saudreau, V ;
Delmas, B ;
Valensi, F ;
Cacoub, P ;
Brechot, C ;
Varet, B ;
Troussard, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (02) :89-94
[29]   Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1 VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas [J].
Ivanovski, M ;
Silvestri, F ;
Pozzato, G ;
Anand, S ;
Mazzaro, C ;
Burrone, OR ;
Efremov, DG .
BLOOD, 1998, 91 (07) :2433-2442
[30]  
Kallemuchikkal U, 1999, ARCH PATHOL LAB MED, V123, P119